Metabolic inhibitors and renal ischemia.
D000818:Animals; D000963:Antimetabolites / Q000627:therapeutic use*; D003404:Creatinine / Q000097:blood; D003486:Cyanides / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D007511:Ischemia / Q000517:prevention & control; D007668:Kidney / Q000098:blood supply* / Q000187:drug effects; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008297:Male; D009840:Oligomycins / Q000627:therapeutic use; D010042:Ouabain / Q000627:therapeutic use; D011809:Quinones / Q000627:therapeutic use; D051381:Rats; D011919:Rats, Inbred Strains; D012964:Sodium / Q000627:therapeutic use; D014021:Tissue Preservation; D014022:Tissue Survival
D000963:Antimetabolites; D003486:Cyanides; D009840:Oligomycins; D011809:Quinones; D010042:Ouabain; D008278:Magnesium Sulfate; D005665:Furosemide; D012964:Sodium; D003404:Creatinine; D004976:Ethacrynic Acid